Keys Jordan, Markham Jessica L, Hall Matthew, Goodwin Emily J, Linebarger Jennifer, Bettenhausen Jessica L
Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri, USA.
University of Missouri, Kansas City, Missouri, USA.
J Hosp Med. 2025 May;20(5):446-453. doi: 10.1002/jhm.13539. Epub 2024 Oct 24.
Treatment of postoperative pain for children with severe neurologic impairment (SNI) is challenging. We describe the type, number of classes, and duration of postoperative pain medications for procedures common among children with SNI, as well as the variability across children's hospitals in pain management with an emphasis on opioid prescribing.
This retrospective cohort study included children with SNI ages 0-21 years old who underwent common procedures between January 1, 2019 and December 31, 2019 within 49 children's hospitals in the Pediatric Health Information System. We defined SNI using previously described high-intensity neurologic impairment diagnosis codes and identified six common procedures which included fracture treatment, tracheostomy, spinal fusion, ventriculoperitoneal shunt placement (VP shunt), colostomy, or heart valve repair. Medication classes included benzodiazepines, opioids, and other nonopioid pain medications. Acetaminophen and nonsteroidal anti-inflammatory drugs were excluded from analysis. All findings were summarized using bivariate statistics.
A total of 7184 children with SNI underwent a procedure of interest. The median number of classes of pain medications administered varied by procedure (e.g., VP shunt: 0 (interquartile range [IQR] 0-1); tracheostomy: 3 (IQR 2-4)). Across all procedures, opioids and benzodiazepines were the most commonly prescribed pain medications (48.8% and 38.7%, respectively). We observed significant variability in the percentage of postoperative days with opioids across hospitals by procedure (all p < .001).
There is substantial variability in the postoperative delivery of pain medications for children with SNI. A standardized approach may decrease the variability in postoperative pain control and enhance care for children with SNI.
治疗严重神经功能障碍(SNI)儿童的术后疼痛具有挑战性。我们描述了SNI儿童常见手术术后疼痛药物的类型、种类数量和使用时长,以及儿童医院在疼痛管理方面的差异,重点关注阿片类药物的处方情况。
这项回顾性队列研究纳入了2019年1月1日至2019年12月31日期间在儿科健康信息系统中49家儿童医院接受常见手术的0至21岁SNI儿童。我们使用先前描述的高强度神经功能障碍诊断代码定义SNI,并确定了六种常见手术,包括骨折治疗、气管造口术、脊柱融合术、脑室腹腔分流术(VP分流术)、结肠造口术或心脏瓣膜修复术。药物种类包括苯二氮䓬类、阿片类药物和其他非阿片类疼痛药物。对乙酰氨基酚和非甾体抗炎药被排除在分析之外。所有结果均使用双变量统计进行总结。
共有7184名SNI儿童接受了相关手术。所使用的疼痛药物种类中位数因手术而异(例如,VP分流术:0种(四分位间距[IQR]为0 - 1);气管造口术:3种(IQR为2 - 4))。在所有手术中,阿片类药物和苯二氮䓬类药物是最常用的疼痛药物(分别为48.8%和38.7%)。我们观察到不同医院因手术不同,使用阿片类药物的术后天数百分比存在显著差异(所有p < 0.001)。
SNI儿童术后疼痛药物的使用存在很大差异。标准化方法可能会减少术后疼痛控制的差异,并改善对SNI儿童的护理。